Professor Lewis C. Cantley, director of the cancer center at Weill Cornell Medical College and NewYork-Presbyterian Hospital, New York, the U.S., has been selected as the recipient of the Jacobæus Prize 2013. The Prize is awarded annually by the Novo Nordisk Foundation to an internationally recognized researcher for extraordinary achievements within medical research.
Professor Cantley is awarded the Prize for his achievements within cancer research. The American professor and doctor has made significant advances in cancer research stemming from his discovery of the signaling pathway phosphoinositide 3-kinase (PI3K) in the mid-1980s, which explains the growth of a cell and has major implications in cancer. Through his pioneering research, Dr. Cantley has discovered that human cancers frequently have mutations in PI3K and, for the past three decades, he has worked to identify new treatments for cancers that result from defects in the pathway. This discovery, which has led to one of the most promising avenues for the development of personalized cancer therapies, has since resulted in revolutionary treatments for cancer, diabetes and autoimmune diseases.
The Prize is unanimously awarded by the Nordic Research Committee, the committee of the Novo Nordisk Foundation which awards the Prize. Dr. Cantley is the 68th recipient of the Jacobæus Prize, which was established in 1939 and is the oldest prize of the Foundation. The Prize includes an amount of DKK 100,000 and the prizewinner is invited to give a lecture on his research, the H.C. Jacobæus Lecture.
The lecture takes place at the annual H.C. Jacobæus Symposium, this year held on 15 November at the Karolinska Institutet in Stockholm. The event is open to the press.
- It is a tremendous honor to receive the Jacobæus Prize, Dr. Cantley said.
- This is one of the oldest and most prestigious prizes in science. I look forward to the ceremony in Stockholm and the opportunity to present some interesting findings from my laboratory in relation to targeting PI3K for cancer therapy.
The Prize honors Hans Christian Jacobæus (1879-1937), who was a respected and well-known Swedish professor and pioneering clinical researcher within the field of lung physiology and pathophysiology. His research includes the development of a method for exploring the pleural cavity (thoracoscopy) using a cystoscope, which greatly improved the diagnosis and treatment of lung diseases, especially tuberculosis.
Christian Mostrup Scheel, Press Officer, Novo Nordisk Foundation, email@example.com, mobile +45 3067 4805
For more info on the Jacobæus Prize and previous recipients, click here.